drugset / Trial / NCT03221933
A Study of Recombinant Human Growth Hormone Injection（JINTOPIN AQ）for Short Children With Small for SGA
Phase 2
Completed
120 enrolled
Changchun GeneScience Pharmaceutical Co., Ltd.
Beijing Children's Hospital · collabShanghai Children's Hospital · collabThe Children's Hospital of Zhejiang University School of Medicine · collabThe First Affiliated Hospital with Nanjing Medical University · collabTongji Hospital · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
To preliminary assess the efficacy and safety of recombinant human growth hormone injection on the treatment of small for gestational age (SGA), and determine the best dose.
Timeline
- Start
- 2009-12
- Primary completion
- 2014-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Somatropin | Protein / enzyme biologic | 0.23 mg/kg | Other |
| Subject | Somatropin | Protein / enzyme biologic | 0.46 mg/kg | Other |